Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 agonists (like Ozempic and Mounjaro) reduced asthma symptoms in obese people according to a new study published in Advances in Therapy
Protein is essential for maintaining muscle mass and providing sustained energy
Whit Bernard, Metsera CEO Metseras long-acting GLP-1 looks competitive in Phase 2 obesity study Data from a mid-stage obesity trial of Metseras long-acting injectable GLP-1 agonist suggest it could be competitive with approved incretins and several investigational compounds
These subtle but meaningful improvements reflect progress in your overall health
US$ 21.01
US$ 26.24
US$ 22.23
